
A new venture capital fund named Chemistry has been launched this week by Mark Goldberg, Ethan Kurz, and Kshenster, with a total capitalization of $350 million. The fund aims to address the evolving needs of founders and the venture capital landscape, emphasizing a shift towards smaller, focused funds that can better align with the goals of startups. The launch follows the announcement of an $8 billion fund, indicating a trend of significant capital influx into the venture space. Discussions among industry experts highlight a generational change in venture capital, where founders are increasingly satisfied with raising varying amounts of capital without the pressure of achieving immediate profitability. The conversation around the fund also touches on the misalignment of incentives within the venture capital industry, advocating for smaller fund sizes and focused investment theses to achieve better long-term outcomes for both investors and founders.

This is a timely reminder that VC-funded companies oftentimes care about very different goals/metrics than bootstrapped ones. “Growth” is usually a more important metric for a VC-funded one than reducing losses/improving profits. B/c without growth it’s hard to raise a new round https://t.co/8TzM2H28Nf
Great encapsulation of the current dynamic in venture market. https://t.co/0B4IEcJo1g
Great conversation btwn @Mark_Goldberg_ & @HarryStebbings diving in to the why behind @chemistry_fund -why we took the plunge, how we're doing things differently for founders, what's the reality behind 'VC platform' & why we felt the time was indeed right for a new venture fund! https://t.co/SLkXHNcm80